[Completion Pneumonectomy and Perioperative Managements].


Journal

Kyobu geka. The Japanese journal of thoracic surgery
ISSN: 0021-5252
Titre abrégé: Kyobu Geka
Pays: Japan
ID NLM: 0413533

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 1 11 2020
pubmed: 2 11 2020
medline: 4 11 2020
Statut: ppublish

Résumé

Completion pneumonectomy (CP) is the complete removal of lung tissue remaining after an initial ipsilateral partial pulmonary resection and is one of the most invasive operations in the field of general thoracic surgery. Mortality and morbidity rates are higher after CP than standard pneumonectomy. CP is a highly demanding procedure, usually due to major pleural and sometimes pericardial dense adhesions from previous surgery or infection. Intra-pericardial control of the pulmonary artery and veins is recommended to avoid vessel injury. Therefore, this operative intervention should be performed only by experienced thoracic surgeons on carefully selected patients in order to improve postoperative outcomes. Preoperative pulmonary and cardiac functions are decreased by the previous procedure. In addition, the rate of complications is high because of excessive operative invasiveness. Therefore, preoperative assessment, surgical indication, low invasive surgical technique, and good postoperative management are very important elements when CP is performed. On the other hands, CP may be a reasonable option for postoperative lung cancer recurrence or new primaries only in carefully selected patients, in whom the potential oncological benefits overweigh the surgical risk. This article reviews these operative knack and pitfalls.

Identifiants

pubmed: 33130772

Types de publication

Journal Article Review

Langues

jpn

Sous-ensembles de citation

IM

Pagination

819-823

Auteurs

Yosuke Matsuura (Y)

Department of Thoracic Surgical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH